Jeong JM - Search Results

1

Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.

Chung JK, Lee YJ, Kim SK, Jeong JM, Lee DS, Lee MC. Chung JK, et al. Among authors: jeong jm. Nucl Med Commun. 2004 Jan;25(1):11-7. doi: 10.1097/00006231-200401000-00003. Nucl Med Commun. 2004. PMID: 15061260 Clinical Trial.

2

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.

Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC. Chung JK, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82. doi: 10.1007/s00259-001-0690-4. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926379

3

In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter.

Min JJ, Chung JK, Lee YJ, Shin JH, Yeo JS, Jeong JM, Lee DS, Bom HS, Lee MC. Min JJ, et al. Among authors: jeong jm. Nucl Med Biol. 2002 Jul;29(5):537-45. doi: 10.1016/s0969-8051(02)00304-9. Nucl Med Biol. 2002. PMID: 12088723

4

Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.

Jeong HJ, Chung JK, Kim YK, Kim CY, Kim DG, Jeong JM, Lee DS, Jung HW, Lee MC. Jeong HJ, et al. Among authors: jeong jm. J Nucl Med. 2002 Nov;43(11):1432-7. J Nucl Med. 2002. PMID: 12411544 Free article.

5

Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.

Shin JH, Chung JK, Kang JH, Lee YJ, Kim KI, Kim CW, Jeong JM, Lee DS, Lee MC. Shin JH, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):425-32. doi: 10.1007/s00259-003-1394-8. Epub 2003 Dec 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 14689242

6

[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.

Kim S, Chung JK, Kang SB, Kim MH, Jeong JM, Lee DS, Lee MC. Kim S, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):196-201. doi: 10.1007/s00259-003-1367-y. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129701 Clinical Trial.

7

Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.

Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Kang WJ, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):202-7. doi: 10.1007/s00259-003-1368-x. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129702 Clinical Trial.

8

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC. Kim S, et al. Among authors: jeong jm. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):52-9. doi: 10.1007/s00259-004-1598-6. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309332

9

Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.

Kang JH, Chung JK, Lee YJ, Shin JH, Jeong JM, Lee DS, Lee MC. Kang JH, et al. Among authors: jeong jm. J Nucl Med. 2004 Sep;45(9):1571-6. J Nucl Med. 2004. PMID: 15347726 Free article.

10

Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging.

Jeong JM, Hong MK, Kim YJ, Lee J, Kang JH, Lee DS, Chung JK, Lee MC. Jeong JM, et al. Nucl Med Commun. 2004 Dec;25(12):1211-7. doi: 10.1097/00006231-200412000-00010. Nucl Med Commun. 2004. PMID: 15640781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters